Tyra Biosciences, Inc.·4

Aug 7, 4:38 PM ET

Warner Douglas J 4

4 · Tyra Biosciences, Inc. · Filed Aug 7, 2025

Insider Transaction Report

Form 4
Period: 2025-08-07
Warner Douglas J
Chief Medical Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-08-07+200,000200,000 total
    Exercise: $10.75Exp: 2035-08-06Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option shall vest on August 7, 2026, and 1/36th of the remaining number of shares subject to the option vest monthly thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4